DECAF Score for Acute Exacerbation of COPD

The DECAF score predicts in‑hospital mortality in acute COPD exacerbations using five admission variables 1 [Level I evidence].

Extended MRC Dyspnea Scale (eMRCD)
Not too dyspneic to leave house (eMRCD 1-4)0Too dyspneic to leave house but independent w/ washing/dressing (eMRCD 5a)+1Too dyspneic to leave house and wash/dress (eMRCD 5b)+2
Eosinopenia
No0Yes+1
Consolidation on CXR
No0Yes+1
Acidemia
No0Yes+1
AFib
No0Yes+1

适用指征

Used for adults hospitalized with acute COPD exacerbation to predict in‑hospital and 30‑day mortality and to guide disposition.
Low scores (0–1) identify patients suitable for Hospital at Home/early supported discharge (validated non‑inferior RCT, 118 pts 1 [Level I evidence]).
Higher scores (≥3) indicate high short‑term mortality risk and need for closer monitoring or escalation (external validation AUROC 0.82–0.83; 1725 pts 2 [Level I evidence]).

洞见与注意事项

Stratifies inpatient mortality risk in AECOPD using five routinely available variables and shows strong discrimination (AUROC ~0.82–0.86) in large internal/external validations 1 [Level I evidence]; 2 [Level II evidence]. Low scores (0–1) reliably identify patients suitable for early supported or home-based care 3 [Level I evidence]. Avoid over-reliance in complex multimorbid or cardiovascular disease–driven presentations, where alternative models may outperform DECAF 4 [Level II evidence].